December 2, 2008UPDATE 2-Data supports Novartis malaria drug -US FDA staff - Forbes UPDATE 2-Data supports Novartis malaria drug -US FDA staff - Forbes
WASHINGTON, Dec 1 (Reuters) - Data show Novartis (nyse: NVS - news - people ) AG's combination malaria drug Coartem appears to work and causes few serious side effects, U.S. Food and Drug Administration regulatory staff said in documents released on Source: www.forbes.com Thermo Fisher Scientific Launches Program to Meet Melamine Detection - WebitPR SAN JOSE, Calif. (December 2, 2008) – Thermo Fisher Scientific Inc., the world leader in serving science, announced it has launched a program focused on assisting government and commercial food testing laboratories in the development and Source: www.webitpr.com FDA speeds up review of Cell Therapeutics drug - Seattle Business Journal The Food and Drug Administration will expedite its review of whether the cancer drug Zevalin can be used in wider applications. Zevalin is being developed by RIT Oncology LLC, a joint venture of Cell Therapeutics Inc. (NASDAQ: CTIC), of Seattle, and Source: seattle.bizjournals.com # posted by Network @ 11:00 AM
 |
Subscribe to Posts [Atom]